Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,735,000 | 2,176,000 | 1,877,000 | 1,759,000 | 1,978,000 |
| Marketable Securities | 26,277,000 | 20,288,000 | 17,391,000 | 15,503,000 | 23,991,000 |
| Receivables | 13,380,000 | 14,302,000 | 14,012,000 | 13,611,000 | 14,645,000 |
| Inventories | 8,275,000 | 8,771,000 | 9,511,000 | 10,132,000 | 12,403,000 |
| Income taxes - deferred | N/A | 7,284,000 | 7,113,000 | 7,502,000 | N/A |
| Other current assets | 11,346,000 | 1,268,000 | 1,197,000 | 1,409,000 | 1,691,000 |
| TOTAL | $61,013,000 | $54,089,000 | $51,101,000 | $49,916,000 | $61,670,000 |
| Non-Current Assets | |||||
| PPE Net | 18,645,000 | 19,450,000 | 20,041,000 | 21,651,000 | 22,780,000 |
| Investments And Advances | 9,747,000 | 10,344,000 | 10,524,000 | 12,081,000 | 13,122,000 |
| Intangibles | 101,483,000 | 102,414,000 | 105,373,000 | 107,128,000 | 110,391,000 |
| Other Non-Current Assets | 4,126,000 | 5,118,000 | 4,032,000 | 4,337,000 | 4,986,000 |
| TOTAL | $134,001,000 | $137,326,000 | $139,970,000 | $145,197,000 | $151,279,000 |
| Total Assets | $195,014,000 | $191,415,000 | $191,071,000 | $195,113,000 | $212,949,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,603,000 | 5,158,000 | 5,509,000 | 7,769,000 | 5,469,000 |
| Accounts payable and accrued liabilities | 3,994,000 | 3,206,000 | 3,078,000 | 3,028,000 | 4,370,000 |
| Accrued Expenses | 2,080,000 | 1,853,000 | 1,789,000 | 2,060,000 | 2,242,000 |
| Other current liabilities | 14,256,000 | N/A | 12,128,000 | 12,301,000 | 13,583,000 |
| TOTAL | $28,636,000 | $24,172,000 | $24,681,000 | $25,924,000 | $37,225,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,410,000 | 39,010,000 | 37,765,000 | 38,281,000 | 43,193,000 |
| Other Non-Current Liabilities | 21,068,000 | 23,220,000 | 24,393,000 | 23,357,000 | 24,247,000 |
| TOTAL | $78,113,000 | $79,175,000 | $79,512,000 | $79,107,000 | $85,278,000 |
| Total Liabilities | $106,749,000 | $103,347,000 | $104,193,000 | $105,031,000 | $122,503,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,995,220 | 8,009,951 | 8,038,278 | 8,066,134 | 8,070,373 |
| Common Shares | 444,000 | 443,000 | 443,000 | 443,000 | 443,000 |
| Retained earnings | 42,716,000 | 42,873,000 | 42,010,000 | 42,429,000 | 40,426,000 |
| Other shareholders' equity | -2,943,000 | -3,219,000 | -3,937,000 | -1,549,000 | 712,000 |
| TOTAL | $88,265,000 | $88,068,000 | $86,878,000 | $90,082,000 | $90,446,000 |
| Total Liabilities And Equity | $195,014,000 | $191,415,000 | $191,071,000 | $195,113,000 | $212,949,000 |